Northwest Biotherapeutics (Nasdaq: NWBO) announced that the Board is committed to adding an additional independent director, and the Company welcomes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE